Compare Charles River Laboratories Intl. Inc (CRL) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? Charles River Laboratories Intl. Inc trades at $227.69 (market cap $11.14B), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $27.56. The key difference: Charles River Laboratories Intl. Inc is trading nearer its 52-week high, ProShares UltraShort Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| CRL | KOLD | |
|---|---|---|
Market Cap | $11.14B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $233.60 | $49.39 |
52-Week Low | $145.57 | $13.58 |
Enterprise Value | $14.00B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
KOLD, the ProShares UltraShort Bloomberg Natural Gas ETF, trades at $27.98, up 3.78% on the day. Technical indicators show a bullish trend with strong moving average support, though RSI levels suggest overbought conditions. Recent news highlights volatility in natural gas futures driven by weather forecasts and LNG demand, with the ETF positioned as a tactical trading tool amid price swings around $3/MMBtu. The overall technical signal is bullish, but oscillators remain neutral, indicating potential near-term consolidation.
The outlook for KOLD is tied to natural gas price volatility, with opportunities for short-term gains if gas prices decline due to rising supply or milder weather. Key risks include unexpected demand spikes from heat waves or geopolitical events, which could pressure the inverse ETF. Investors should monitor EIA storage reports and weather trends closely, as these are primary catalysts for movement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About ProShares UltraShort Bloomberg Natural Gas ETF
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →
